Ensysce Biosciences Inc. Receives Small Business Grant From National Institutes of Health (NIH) to Optimize Single Walled Carbon Nanotube Formulation for Therapeutic Delivery of siRNA

Published: Sep 25, 2012

HOUSTON--(BUSINESS WIRE)--Ensysce Biosciences Inc. announced today they have received a SBIR award of roughly $300,000 to optimize the formulation of their single walled carbon nanotube (SWCNT)/siRNA complex for therapeutic delivery. These funds, along with the recent $1 million dollars that were raised in June and the State of Texas Emerging Technology Funds that had been awarded previously, will allow the finalization of the formulation prior to undertaking Investigational New Drug (IND) enabling studies.

Back to news